Corinne Epperly, MD, MPH is a prominent leader in the biopharmaceutical industry, currently serving as Co-Founder and CEO of Stealth Newco since February 2024, with ongoing roles as a Board Member at IN8bio and Sastra cell therapy. Previously, Corinne held the position of Chief Operating Officer at CARGO Therapeutics, focusing on next-gen CAR-T cell therapies, and was a Board Member at AVEO Oncology. Corinne's extensive experience includes senior roles at Iovance Biotherapeutics, Vascular Biogenics Ltd., and Bristol-Myers Squibb, where responsibilities encompassed medical strategy, safety management in immuno-oncology, and leading global mergers and acquisitions. Educational achievements include a Doctorate of Medicine from the University of North Carolina School of Medicine and a Masters of Public Health from the University of North Carolina School of Global Public Health.
This person is not in the org chart
This person is not in any teams
This person is not in any offices